208 related articles for article (PubMed ID: 8525049)
1. T-cell costimulation via CD28-CD80/CD86 and CD40-CD40 ligand interactions.
Somoza C; Lanier LL
Res Immunol; 1995; 146(3):171-6. PubMed ID: 8525049
[No Abstract] [Full Text] [Related]
2. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
3. Treatment of autoimmunity by inhibition of T cell costimulation.
Daikh DI; Wofsy D
Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
[No Abstract] [Full Text] [Related]
4. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
5. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
Vonderheide RH; Butler MO; Liu JF; Battle TE; Hirano N; Gribben JG; Frank DA; Schultze JL; Nadler LM
Int J Oncol; 2001 Oct; 19(4):791-8. PubMed ID: 11562757
[TBL] [Abstract][Full Text] [Related]
6. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
[No Abstract] [Full Text] [Related]
7. CD28-CD80/86 and CD40-CD40L Interactions Promote Thymic Tolerance by Regulating Medullary Epithelial Cell and Thymocyte Development.
Williams JA; Tai X; Hodes RJ
Crit Rev Immunol; 2015; 35(1):59-76. PubMed ID: 25746048
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
[TBL] [Abstract][Full Text] [Related]
9. Cell-cell interactions regulate dendritic cell-dependent HIV-1 production in CD4+ T lymphocytes.
Pinchuk LM; Polacino PS; Agy MB; Klaus SJ; Clark EA
Adv Exp Med Biol; 1995; 378():461-3. PubMed ID: 8526118
[TBL] [Abstract][Full Text] [Related]
10. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P
Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory molecules (CD80 and CD86) on Reed-Sternberg cells are associated with the proliferation of background T cells in Hodgkin's disease.
Nozawa Y; Wakasa H; Abe M
Pathol Int; 1998 Jan; 48(1):10-4. PubMed ID: 9589458
[TBL] [Abstract][Full Text] [Related]
12. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
Slavik JM; Hutchcroft JE; Bierer BE
J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
[TBL] [Abstract][Full Text] [Related]
13. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
[TBL] [Abstract][Full Text] [Related]
14. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
15. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
16. CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
Linsley PS; Ledbetter J; Peach R; Bajorath J
Res Immunol; 1995; 146(3):130-40. PubMed ID: 8525042
[No Abstract] [Full Text] [Related]
17. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
20. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
